Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Cope

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|February 1, 2021
HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and EndotheliumLiangfeng Han, Preethi Korangath, Nguyen K Nguyen, et al.
Journal of Proteomics & Bioinformatics|July 2, 2011
Identification of Novel Phosphorylation Motifs Through an Integrative Computational and Experimental Analysis of the Human PhosphoproteomeRamars Amanchy, Kumaran Kandasamy, Suresh Mathivanan, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Clinical Breast Cancer|June 15, 2015
A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score AssayMichele M Gage, Martin Rosman, W Charles Mylander, et al.
Cancer Biology & Therapy|May 25, 2006
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasmsKentaro Nakayama, Naomi Nakayama, Robert J Kurman, et al.
Plos One|November 14, 2013
Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysisElana J Fertig, Ana Markovic, Ludmila V Danilova, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
Plos One|November 21, 2012
HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networksSandeep N Shah, Candace Kerr, Leslie Cope, et al.
Cancers|September 30, 2020
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene AssayMichael A Jacobs, Christopher B Umbricht, Vishwa S Parekh, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|February 1, 2021
HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and EndotheliumLiangfeng Han, Preethi Korangath, Nguyen K Nguyen, et al.
Journal of Proteomics & Bioinformatics|July 2, 2011
Identification of Novel Phosphorylation Motifs Through an Integrative Computational and Experimental Analysis of the Human PhosphoproteomeRamars Amanchy, Kumaran Kandasamy, Suresh Mathivanan, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Clinical Breast Cancer|June 15, 2015
A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score AssayMichele M Gage, Martin Rosman, W Charles Mylander, et al.
Cancer Biology & Therapy|May 25, 2006
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasmsKentaro Nakayama, Naomi Nakayama, Robert J Kurman, et al.
Plos One|November 14, 2013
Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysisElana J Fertig, Ana Markovic, Ludmila V Danilova, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
Plos One|November 21, 2012
HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networksSandeep N Shah, Candace Kerr, Leslie Cope, et al.
Cancers|September 30, 2020
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene AssayMichael A Jacobs, Christopher B Umbricht, Vishwa S Parekh, et al.
Pageof 14